Earn CME Credit: https://naccme.com/program/7306
In this presentation from the 23rd Annual Perspectives in Thoracic Oncology, Dr. Lyudmila Bazhenova discusses EGFR resistance in the era of osimertinib.
© 2018 Imedex, an HMP Company
Advertisement
Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib
